OLMEXA 25 MT
OLMEXA 25 MT is used for effective management of hypertension and cardiovascular risk. It contains Olmesartan Medoxomil 20 mg + Metoprolol Succinate 25 mg, offering dual action for better blood pressure control. Olmesartan relaxes blood vessels by blocking angiotensin II, while Metoprolol reduces heart rate and cardiac workload. This combination helps maintain stable blood pressure, supports heart health, and is commonly prescribed for long-term cardiovascular protection.
Related products
METOMED AM 50
METOMED AM 50 is a combination therapy used for effective management of hypertension and related...
TELLME 20 CT 6.25
TELLME 20 CT 6.25 contains Telmisartan 20 mg + Chlorthalidone 6.25 mg. Telmisartan helps relax...
TELLME MT 25
TELLME MT 25 is a combination of Telmisartan 40 mg + Metoprolol 25 mg. Telmisartan...
TELLME 80 CL
TELLME 80 CL contains Telmisartan 80 mg + Cilnidipine 10 mg, designed for patients needing...
TELLME 40 CL
TELLME 40 CL is a combination of Telmisartan 40 mg + Cilnidipine 10 mg. Telmisartan...
TELLME AMH
Composition : Telmisartan 40 mg + Amlodipine 5 mg + Hydrochlorothiazide 12.5 mg.
